CN101130020A - 参胡清肺散 - Google Patents
参胡清肺散 Download PDFInfo
- Publication number
- CN101130020A CN101130020A CNA2007100708763A CN200710070876A CN101130020A CN 101130020 A CN101130020 A CN 101130020A CN A2007100708763 A CNA2007100708763 A CN A2007100708763A CN 200710070876 A CN200710070876 A CN 200710070876A CN 101130020 A CN101130020 A CN 101130020A
- Authority
- CN
- China
- Prior art keywords
- radix
- grams
- gram
- powder
- medical material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 39
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 11
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 11
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 11
- 241000208340 Araliaceae Species 0.000 title claims description 10
- 239000003814 drug Substances 0.000 title description 4
- 201000003453 lung abscess Diseases 0.000 claims abstract description 7
- 210000000582 semen Anatomy 0.000 claims description 18
- 239000012567 medical material Substances 0.000 claims description 15
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000012467 final product Substances 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 238000012216 screening Methods 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- 239000010419 fine particle Substances 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 2
- 241000411851 herbal medicine Species 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims 1
- 244000080767 Areca catechu Species 0.000 abstract 1
- 235000006226 Areca catechu Nutrition 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 240000002948 Ophiopogon intermedius Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000006751 Platycodon Nutrition 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 240000007641 Spergula rubra Species 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 229930189914 platycodon Natural products 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种具有治疗肺痈的中成药散剂技术领域，由以下配方配比组成：玄参2.4克，银柴胡、陈皮、桔梗、茯苓、地骨皮、麦冬各3克，苡仁6克，人参、甘草各1.5克，槟榔0.9克，生姜1片，本发明具有清肺化痰的功能，治疗肺痈恢复期，身热渐退，咳吐脓痰少等症状有显著的疗效。
Description
技术领域
本发明涉及一种中成药散剂技术领域，尤其是治疗肺痈的散剂。
背景技术
现有的治疗肺痈的药物，大多具有以下特点：
1.效果不显著；
2.疗程长；
3.费用昂贵；
4.停药易反复；
5.病人对药物的依赖性强。
发明内容
本发明的任务是为其提供一种制作方便、无副作用、对于治疗肺痈的散剂。
一种治疗肺痈的散剂，所提供的技术方案是：取玄参2.4克，银柴胡、陈皮、桔梗、茯苓、地骨皮、麦冬各3克，苡仁6克，人参、甘草各1.5克，槟榔0.9克，生姜1片，药材配置好后，将其粉碎成粗粉，混合均匀，再干燥粉碎成细粉，筛分药材，按规定分剂量包装即可。
本发明所提供的工序是：
1.配置药材，祛除杂质；
2.粉碎药材，将处方上药材粉碎成粗粉并混合均匀；
3.干燥。散剂制剂的水分不得超过90.％，必须进行人工干燥或其他；
4.再粉碎。将干燥后的粗粉粉末粉碎成细粉；
5.筛分。粉碎成细粉的粉末进行震动筛分，保证细粉颗粒的大小均匀标准；
6.包装。按照规定将细粉分剂量包装即可。
玄参清热解毒、滋阴散结、有降血压、降血糖、抗菌、退热的作用；柴胡疏肝解郁、退热和解、有退热、保护肝脏的功效；陈皮有助于食物的消化，可促进消化液的分泌，排除肠管内积气，增加食欲，还有理气调中、燥湿化痰的功效；桔梗宣肺化痰、排脓利咽、有化痰、止咳的作用；茯苓利水燥湿、安神健脾、有增强机体免疫力、利尿、抗菌的作用；地骨皮味甘，性寒，具有清虚热、泻肺火、凉血的功效；麦冬具有养明清热、润肺止咳强心、利尿、抗菌的作用；苡仁利水燥湿、健脾、清热解毒、缓和挛急、有抗肿瘤、消除疲劳、降低血压、镇痛、解热的作用；人参大补元气，补益脾肺，生津止渴，安神益智，具有抗疲劳、调节机体代谢、抗肿瘤；甘草补益中气、化痰止咳、清热解毒、止痛缓急、调和百药、有解毒、镇咳、降胆固醇、抗肿瘤、退热、保护消化系统的作用；槟榔气味苦辛温涩、无毒，消谷逐水除痰辟；生姜解表发汗、温中止吐、止咳润肺。本品具有助消化、兴奋、防止血管硬化、抗菌的作用。
本发明对治疗肺痈有显著疗效，治疗效果彻底，复发几率低，长期服用无副作用。
具体实施方案
参胡清肺散由以下配方配比组成：取玄参2.4克，银柴胡、陈皮、桔梗、茯苓、地骨皮、麦冬各3克，苡仁6克，人参、甘草各1.5克，槟榔0.9克，生姜1片，药材配置好后，将其粉碎成粗粉，混合均匀，再干燥粉碎成细粉，筛分药材，按规定分剂量包装即可，在具体实施过程中，若有伤寒者，可加仓术、甘草；若有贫血者，加当归、白芍。
下面结合具体操作方案说明：
实施例一
配伍：玄参2.4克，银柴胡、陈皮、桔梗、茯苓、地骨皮、麦冬各3克，苡仁6克，人参、甘草各1.5克，槟榔0.9克，生姜1片。
制备方法：
1.配置药材，祛除杂质；
2.粉碎药材，将处方上药材粉碎成粗粉并混合均匀；
3.干燥。散剂制剂的水分不得超过90.％，必须进行人工干燥或其他；
4.再粉碎。将干燥后的粗粉粉末粉碎成细粉；
5.筛分。粉碎成细粉的粉末进行震动筛分，保证细粉颗粒的大小均匀标准；
6.包装。按照规定将细粉分剂量包装即可。
实施例二
配伍：玄参2.4克，银柴胡、陈皮、桔梗、茯苓、地骨皮、麦冬各3克，苡仁6克，人参、甘草各1.5克，槟榔0.9克，生姜1片，仓术、甘草各3克。
制备方法同实施例一。
实施例三
配伍：玄参2.4克，银柴胡、陈皮、桔梗、茯苓、地骨皮、麦冬各3克，苡仁6克，人参、甘草各1.5克，槟榔0.9克，生姜1片当归、白芍各4.5克。
制备方法同实施例一。
Claims (3)
1.一种具有治疗肺痈的中成药散剂，其特征在于玄参2.4克，银柴胡、陈皮、桔梗、茯苓、地骨皮、麦冬各3克，苡仁6克，人参、甘草各1.5克，槟榔0.9克，生姜1片，药材配置好后，将其粉碎成粗粉，混合均匀，再干燥粉碎成细粉，筛分药材，按规定分剂量包装即可。
2.根据权利要求1所述，其特征在于制备方法是：
●配置药材，祛除杂质；
●粉碎药材，将处方上药材粉碎成粗粉并混合均匀；
●干燥，散剂制剂的水分不得超过90％，必须进行人工干燥或其他；
●再粉碎，将干燥后的粗粉粉末粉碎成细粉；
●筛分，粉碎成细粉的粉末进行震动筛分，保证细粉颗粒的大小均匀标准；
●包装，按照规定将细粉分剂量包装即可。
3.根据权利要求1所述，其特征在于两个配方配比是玄参2.4克，银柴胡、陈皮、桔梗、茯苓、地骨皮、麦冬各3克，苡仁6克，人参、甘草各1.5克，槟榔0.9克，生姜1片，仓术、甘草各3克和玄参2.4克，银柴胡、陈皮、桔梗、茯苓、地骨皮、麦冬各3克，苡仁6克，人参、甘草各1.5克，槟榔0.9克，生姜1片当归、白芍各4.5克。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100708763A CN101130020A (zh) | 2007-08-21 | 2007-08-21 | 参胡清肺散 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100708763A CN101130020A (zh) | 2007-08-21 | 2007-08-21 | 参胡清肺散 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101130020A true CN101130020A (zh) | 2008-02-27 |
Family
ID=39127532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007100708763A Pending CN101130020A (zh) | 2007-08-21 | 2007-08-21 | 参胡清肺散 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101130020A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102047988B (zh) * | 2009-10-29 | 2013-01-16 | 于凤洋 | 一种茶叶泡袋 |
| CN104274683A (zh) * | 2014-10-30 | 2015-01-14 | 淄博夸克医药技术有限公司 | 一种治疗肺痈的中药组合物及制备方法和应用 |
| WO2022242128A1 (zh) * | 2021-05-20 | 2022-11-24 | 天津中医药大学 | 一种感染性疾病康复用的中药组合物及其用途 |
-
2007
- 2007-08-21 CN CNA2007100708763A patent/CN101130020A/zh active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102047988B (zh) * | 2009-10-29 | 2013-01-16 | 于凤洋 | 一种茶叶泡袋 |
| CN104274683A (zh) * | 2014-10-30 | 2015-01-14 | 淄博夸克医药技术有限公司 | 一种治疗肺痈的中药组合物及制备方法和应用 |
| WO2022242128A1 (zh) * | 2021-05-20 | 2022-11-24 | 天津中医药大学 | 一种感染性疾病康复用的中药组合物及其用途 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101062266A (zh) | 泻火止咳散 | |
| CN100398147C (zh) | 防治脱发的中药制剂及其制备方法 | |
| CN101130023A (zh) | 党参温胃散 | |
| CN102048899A (zh) | 治疗阳痿的中药制剂 | |
| CN101062212A (zh) | 治疗胃炎的中药组合物 | |
| CN102205059A (zh) | 一种治疗肝、胃、肺、血癌的中草药组合物及制备方法 | |
| CN101130020A (zh) | 参胡清肺散 | |
| CN101062213A (zh) | 陈皮半夏汤 | |
| CN101757206A (zh) | 用于治疗慢性结肠炎的中药制剂 | |
| CN105031244A (zh) | 一种养生保健酒及其制作方法 | |
| CN104173727A (zh) | 一种治疗牙痛的药物 | |
| CN101229358A (zh) | 一种治疗肺炎和肺气肿的中药组合物及其制备方法 | |
| CN103392867A (zh) | 排毒养颜保健茶 | |
| CN102813733A (zh) | 一种抗癌、预防糖尿病、增强免疫力的药茶 | |
| CN105267768A (zh) | 一种治疗口腔溃疡的外用药物 | |
| CN101664517A (zh) | 一种治疗脑炎的中药 | |
| CN1899556A (zh) | 一种治疗气管炎、哮喘的药物 | |
| CN101062248A (zh) | 生地茯苓口服液 | |
| CN1062176C (zh) | 一种治疗癌症的口服液 | |
| CN1883663A (zh) | 一种治疗慢性鼻、咽炎和梅核气疾病的纯中药 | |
| CN101129686A (zh) | 柴勺胃痛散 | |
| CN102225141A (zh) | 一种治疗慢性咽喉炎的中药含片 | |
| CN101444616B (zh) | 一种治疗慢性风湿病痛的药酒及其制备方法 | |
| CN101991802A (zh) | 治疗感冒咳嗽的中药制剂 | |
| CN101991762A (zh) | 治疗顽固性哮喘的中药及制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20080227 |